Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/14/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 10/29/21
End: 02/03/23
Due: 02/03/24
Phase: N/A
Priority: Normal
Start: 02/21/24
End: 08/31/26
Due: 08/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin | NCT06517563 | VarmX B.V. | user2@example.com | None | 2024-08-14 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |
| Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects | NCT05152420 | VarmX B.V. | user2@example.com | None | 2021-10-29 | 2023-02-03 | 2024-02-03 | - | - | 2025-07-14 |
| Single Dose Trial of VMX-C001 in Healthy Subjects with and Without FXa Direct Oral Anticoagulant | NCT06372483 | VarmX B.V. | user2@example.com | None | 2024-02-21 | 2026-08-31 | 2027-08-31 | - | - | 2025-07-14 |